查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856651

按產品類型、技術、測試類型、最終用戶、應用和分銷管道照護現場和快速診斷市場—2025-2032年全球預測

Point of Care & Rapid Diagnostics Market by Product Type, Technology, Test Type, End User, Application, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，照護現場將達到 912.1 億美元，複合年成長率為 7.31%。

關鍵市場統計數據
基準年 2024 518.5億美元
預計年份：2025年 556.1億美元
預測年份 2032 912.1億美元
複合年成長率 (%) 7.31%

重點闡述了快速診斷如何分散檢測流程，並在照護端重新定義臨床決策時間軸。

即時檢測和快速診斷正在重塑臨床工作流程，使患者能夠更方便地獲得可操作的檢測結果，並加快臨床決策週期。試劑化學、小型化分析儀、高效能讀數器和資料管理軟體的進步，使得在門診中心、診所、居家照護機構和醫院開展分散式檢查成為可能。隨著設備操作更加便捷、互聯性更強，臨床醫生能夠更早地進行干預，更有效地進行分診，從而改變患者的診療路徑和資源分配。

此外，隨著相關人員將價值導向的醫療結果置於優先地位，快速、可靠且能提供可操作數據的診斷方法正成為一項切實可行的優先事項。實驗室和診斷網路正在努力平衡中心檢測和照護現場能力，以在保證品質的同時提高速度。同時，製造商正在投資整合軟體和支援服務，以確保互通性並降低現有設備的整體擁有成本。技術進步、不斷變化的醫療模式以及對及時結果日益成長的期望，共同創造了一個動態的環境，在這個環境中，臨床獲益、報銷途徑和商業性執行必須協調一致才能取得成功。

技術融合、法規演變和醫療服務模式變革導致市場動態發生變化。

多種因素正在改變診斷檢測的方式和地點。分子診斷、免疫測量和小型臨床化學平台的技術進步，使得在較小的空間內實現更高的分析性能成為可能。同時，資料管理軟體正從孤立的資料收集轉向整合解決方案，從而促進與電子健康記錄和遠端醫療平台的互通性。監管機構也在調整核准流程，以更積極地接受新的即時檢測（POC​​）技術，如果製造商能夠滿足品質和驗證要求，則可以縮短臨床應用的時間。

同時，向門診病人治療和家庭監測的轉變迫使製造商重新評估外形規格、易用性和通路策略。包括直銷、分銷商、電商平台和線上零售在內的分銷管道正在最佳化，以觸及新的終端用戶，並透過增強的服務模式來維持售後支援。隨著相關人員的調整，投資於模組化儀器架構、可擴展試劑系統和雲端分析的市場新參與企業將佔據有利地位，從而在心臟護理、糖尿病管理、感染疾病診斷、腫瘤應用等領域搶佔先機。這意味著下一階段將獎勵將硬體、耗材和軟體整合到以用戶為中心的解決方案中的跨領域整合。

分析近期美國關稅措施對診斷生態系內的供應鏈、籌資策略和創新所產生的累積影響

關稅政策的變化為診斷組件、試劑和成品設備的全球供應鏈帶來了顯著的摩擦。依賴跨境採購分析儀、讀數儀、試劑和關鍵電子元件的製造商正在調整其供應商組合和生產地點，以降低這種風險。採購團隊正致力於供應商多元化和合約彈性，以應對成本波動和物流延誤。

此外，關稅也影響企業在本地組裝和區域製造方面的決策，因為企業需要權衡生產成本上升與供應彈性所帶來的效益。醫院、診所和診斷實驗室的採購負責人正面臨著採購週期延長的問題，因為相關人員希望明確土地購置成本和服務合約的相關事宜。同時，供應商正在加快對自動化和品管的投資，以抵消更高的單位成本並保護利潤率，同時又不影響產品性能。

展望未來，那些積極重新思考籌資策略、優先考慮設備設計模組化以使用相容組件、並加強跨分銷管道策略夥伴關係的公司，更有可能降低關稅帶來的風險。同樣重要的是，監管機構和醫保報銷相關人員需要考慮這些商業性應對措施對高影響力領域（例如分子檢測和免疫檢測）的准入和創新速度的累積影響。

提供可操作的細分洞察，揭示跨產品類型、技術和最終用戶環境的需求促進因素和商業化重點

從產品類型角度來看，耗材、儀器以及軟體和服務有著截然不同的需求。耗材（包括試劑和檢測套組）強調批間一致性、貨架期穩定性以及供應鏈的連續性；儀器（包括分析儀和讀數儀）則優先考慮穩健性、運作和易於維護；而數據管理軟體和支援服務則需要具備安全的互通性、強大的分析能力以及可擴展的服務合約。臨床化學、血液學、免疫檢測和分子診斷領域的技術碎片化導致了檢驗路徑和使用者期望的多樣性。

在考慮諸如心臟標記、凝血功能、血糖監測、感染疾病和妊娠/生育力檢測等檢測類型時，商業化策略必須與臨床路徑和報銷實際情況相符，才能支持臨床醫生採用這些檢測方法。終端用戶細分錶明，門診醫療中心和診所優先考慮快速週轉和便攜性，診斷實驗室重視吞吐量和集中化，居家醫療環境追求簡便性和遠程資料整合，而醫院則需要整合到複雜的IT生態系統中。以應用為中心的策略，例如心臟護理、血液凝固檢驗、糖尿病管理、感染疾病診斷、腫瘤學和妊娠檢測，必須在分析嚴謹性和以使用者為中心的設計之間取得平衡。最後，分銷管道的選擇——直銷、分銷商、電子商務平台或線上零售——會影響定價、保固模式和售後支持，因此通路策略是市場准入和客戶滿意度的核心決定因素。

在不同醫療保健系統和市場環境中部署POC解決方案的區域動態和實際考量

美洲地區呈現出集中式實驗室網路與門診病人和家庭環境中即時檢測（POC​​）部署不斷擴展的多元化格局，這為實現電子健康記錄整合和遠端監測的技術創造了機會。歐洲、中東和非洲由於報銷結構和基礎設施成熟度的差異，其技術應用曲線各不相同。一些市場將快速診斷納入國家篩檢和公共衛生舉措，而其他市場則優先考慮實驗室整合。亞太地區的成長得益於對分散式醫療路徑的投資、慢性病管理計畫的增加以及具有競爭力的製造業基礎，這些因素正在加速產品在地化進程。

在所有地區，監管協調、報銷政策清晰明確以及供應鏈韌性仍然是成功商業化的關鍵因素。以本地為導向的培訓和支援模式、量身定做的定價策略以及與臨床網路的合作將有助於產品的推廣應用。此外，與區域交換醫療資訊平台和遠端醫療平台的互通性將增強產品的臨床價值提案。最終，能夠將全球最佳實踐與本地執行能力相結合的公司將在美洲、歐洲、中東和非洲以及亞太地區實現顯著的市場普及。

競爭格局分析，重點在於影響市場定位的產品系列、服務提案和夥伴關係模式。

在即時檢測 (POC) 和快速診斷領域，主要企業正透過整合解決方案脫穎而出，這些解決方案將模組化分析儀與耗材生態系統和雲端資料平台結合。產品系列融合了可靠的試劑、靈活的檢測套組以及專為運作設計的設備，為診斷實驗室和醫院系統創造了巨大的價值。同樣，投資於資料管理軟體和全面支援服務的機構，透過確保連接性、合規性和全生命週期可維護性，降低了部署阻力。

為了加速檢驗並產生真實世界證據，夥伴關係模式正轉向與臨床機構和技術提供者的共同開發契約。融合直銷、經銷商合作和數位化通路的分銷策略，能夠在維持本地服務能力的同時，擴大市場覆蓋範圍。競爭優勢越來越取決於企業展示成果、降低整體擁有成本、提供一體化售後支援的能力。在效能、卓越服務和互通性決定買家偏好的市場中，那些能夠將產品開發與臨床醫生工作流程相結合，並利用夥伴關係關係提供端到端解決方案的公司，將更具優勢。

為行業領導者提供切實可行的、優先排序的建議，以加速採用新技術、保護利潤率並確保其營運面向未來。

製造商正優先考慮模組化儀器架構，這種架構便於組件更換和維護，從而降低供應鏈中斷對營運的影響。同時，投資於支援互通性和遠距離診斷的資料管理軟體將增強臨床醫生的信心，並支援基於服務的收入模式。從商業性角度來看，將定價和報銷策略與臨床結果和總醫療成本掛鉤，將推動醫院網路和門診管道的採用。

在營運方面，企業應加強多元化採購策略，考慮建立區域製造夥伴關係以減輕關稅影響，並實施靈活的庫存管理。與臨床試驗中心進行策略合作，進行早期檢驗和真實世界證據的生成，將有助於加速支付方參與和臨床醫師採納。最後，建構靈活的分銷模式，結合直銷、精心挑選的經銷商和數位化商務，可以在擴大覆蓋範圍的同時，維持售後服務標準。這些措施的結合將使企業領導者能夠在快速技術創新和醫療服務模式不斷演變的環境中，最大限度地發揮影響力、保持淨利率並保持敏捷性。

嚴謹的調查方法和資料整合方法產生了可重複的見解和檢驗的結論。

此研究過程整合了定性和定量證據，以深入了解市場動態。主要資料來源包括對來自醫院、診斷實驗室、門診中心和居家照護機構的臨床決策者、採購負責人和產品經理進行的結構化訪談。二級資訊來源包括同行評審文獻、監管指南和公司資訊披露，以驗證技術趨勢、檢驗要求和商業模式。

資料綜合分析採用主題分析法，旨在了解通用的採納障礙和促進因素，同時透過比較案例研究，重點介紹不同地區的成功採納模式。在整個調查方法中，我們確保結論是基於檢驗的專家意見和已記錄的績效特徵，而非推測性的預測。這種方法優先考慮假設的透明度和已記錄的局限性，使讀者能夠在適當的營運背景下解讀我們的研究結果。這種嚴謹的調查方法能夠得出可複製、可操作的見解，並可應用於策略制定、產品開發和商業規劃。

總結性觀點，概括了決策者在引領照護現場考慮的策略意義和優先事項。

快速診斷生態系統正處於曲折點，技術進步與不斷變化的醫療服務模式和政策環境交匯融合。決策者必須優先考慮硬體、耗材和軟體的整合，以在供應鏈和交易動態動態的情況下，提供持續的臨床價值並維持營運韌性。同樣重要的是，要使商業化策略與最終用戶的工作流程、報銷實際情況以及當地醫療保健系統的特徵相契合。

未來，成功的企業將具備以下特點：將卓越的產品與強大的服務和數據策略相結合，投資於區域營運的靈活性，並建立能夠加速檢驗和推廣的夥伴關係關係。注重模組化、互通性和以結果為導向的證據生成，將使相關人員能夠把診斷創新轉化為患者照護方面可衡量的改進。總之，永續成長之路取決於嚴謹的執行，即連結技術能力和實際市場應用。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 在資源匱乏地區採用基於智慧型手機的橫向流動化驗進行分散式傳染病篩檢
  • 將人工智慧演算法整合到照護現場血液分析儀中，用於快速評估心血管風險
  • 開發用於床邊同時檢測多種呼吸道病原體的連接複用微流體晶片
  • 擴大基於 CRISPR 的照護現場平台規模，用於快速檢測新出現的病毒變異株
  • 用於連續血糖監測和即時糖尿病護理管理的穿戴式生物感測器貼片的應用
  • 數位健康應用程式和家庭檢測服務推動了面向消費者的快速診斷試劑套件的興起
  • 在分散式照護現場診斷網路中採用區塊鏈技術實現安全資料共用
  • 紙基生物感測條的出現，為經濟高效照護現場檢測水樣本中的重金屬污染物提供了可能。
  • 診斷藥物生產商與製藥公司合作，開發個人化癌症治療中的伴隨快速檢測方法

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按產品類型照護現場和快速診斷市場

  • 消耗品
    • 試劑
    • 檢測套組
  • 裝置
    • 分析器
    • 領導者
  • 軟體與服務
    • 資料管理軟體
    • 支援服務

第9章 按技術照護現場和快速診斷市場

  • 臨床化學
  • 血液學
  • 免疫檢測
  • 分子診斷

第10章 按檢測類型照護現場和快速診斷市場

  • 心臟標記物
  • 凝血
  • 血糖監測
  • 感染疾病
  • 懷孕和不孕症

第11章 按最終用戶照護現場和快速診斷市場

  • 門診醫療中心
  • 診所
  • 診斷實驗室
  • 居家照護
  • 醫院

第12章 按應用程式分類的照護現場和快速診斷市場

  • 心臟護理
  • 血液凝固檢驗
  • 糖尿病管理
  • 感染疾病診斷
  • 腫瘤學
  • 妊娠測試

第13章 按分銷管道照護現場和快速診斷市場

  • 直銷
  • 經銷商
  • 電子商務平台
  • 線上零售

第14章 按地區照護現場和快速診斷市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 按集團照護現場和快速診斷市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國照護現場與快速診斷市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • Roche Diagnostics International AG
    • Siemens Healthineers AG
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson and Company
    • bioMerieux SA
    • Quidel Corporation
    • Ortho Clinical Diagnostics GmbH
    • QIAGEN NV
Product Code: MRR-742BD5183A2E

The Point of Care & Rapid Diagnostics Market is projected to grow by USD 91.21 billion at a CAGR of 7.31% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 51.85 billion
Estimated Year [2025] USD 55.61 billion
Forecast Year [2032] USD 91.21 billion
CAGR (%) 7.31%

A clear-eyed orientation to how rapid diagnostics are decentralizing testing workflows and redefining clinical decision timelines across care settings

Point of care and rapid diagnostics are reshaping clinical workflows by delivering actionable results closer to patients and accelerating clinical decision cycles. Advances in reagent chemistry, miniaturized analyzers, robust readers, and data management software are enabling decentralized testing across ambulatory care centers, clinics, home care settings, and hospitals. As devices become easier to operate and connectivity improves, clinicians are better positioned to intervene earlier and to triage care more effectively, which in turn alters patient pathways and resource allocation.

Furthermore, as stakeholders increasingly prioritize value-based outcomes, diagnostics that deliver rapid, reliable, and actionable data are gaining practical priority. Laboratories and diagnostic networks are balancing central testing capacity with point of care capabilities to maintain quality while improving speed. Meanwhile, manufacturers are investing in integrated software and support services to ensure interoperability and to reduce total cost of ownership across installed bases. This intersection of technological progress, shifting care models, and rising expectations for timely results is creating a dynamic environment where clinical benefits, reimbursement pathways, and commercial execution must align for success

Transformative shifts in market dynamics driven by technological convergence, regulatory evolution, and changing care delivery models

The landscape is experiencing several converging drivers that are transforming where and how diagnostic testing occurs. Technological progress in molecular diagnostics, immunoassays, and compact clinical chemistry platforms is enabling higher analytical performance in smaller footprints. At the same time, data management software is moving from siloed data capture to integrated solutions that facilitate interoperability with electronic health records and telehealth platforms. Regulatory agencies are also adapting pathways to better accommodate novel point of care technologies, which reduces time to clinical adoption when manufacturers can meet quality and validation expectations.

Concurrently, the shift toward outpatient care and home-based monitoring is prompting manufacturers to re-evaluate form factors, ease of use, and channel strategies. Distribution channels that include direct sales, distributors, e-commerce platforms, and online retail are being optimized to reach new end users while maintaining post-market support through enhanced service models. As stakeholders adapt, market participants that invest in modular instrument architectures, scalable reagent systems, and cloud-enabled analytics will be better positioned to capture demand across cardiac care, diabetes management, infectious disease diagnostics, and oncology applications. In short, the next phase will reward cross-disciplinary integration that connects hardware, consumables, and software into user-centric solutions

Analysis of cumulative impacts from recent United States tariff actions on supply chains, procurement strategies, and innovation within the diagnostics ecosystem

Tariff policy shifts have introduced measurable friction into global supply chains for diagnostics components, reagents, and finished instruments. Manufacturers that rely on cross-border sourcing for analyzers, readers, reagents, or critical electronic components have adjusted supplier portfolios and production footprints to mitigate exposure. This rebalancing has driven near-term cost management activity and strategic sourcing efforts, with procurement teams focusing on supplier diversification and contractual flexibility to absorb cost volatility and logistical delays.

In addition, tariffs have influenced decisions about local assembly and regional manufacturing presence as companies evaluate the tradeoffs between incremental production costs and the benefits of supply resilience. For purchasers in hospitals, clinics, and diagnostic laboratories, procurement cycles are lengthening as stakeholders seek clarity around landed costs and service agreements. Meanwhile, suppliers are accelerating investments in automation and quality control to offset higher per-unit costs and to preserve margins without compromising product performance.

Looking forward, firms that proactively redesign sourcing strategies, prioritize modularity in instrument design to leverage interchangeable components, and strengthen strategic partnerships across distribution channels will reduce tariff-driven exposure. Equally important, regulatory and reimbursement stakeholders will need to consider the cumulative effect of these commercial responses on access and on the pace of innovation in high-impact areas such as molecular and immunoassay testing

Actionable segmentation insights that highlight demand drivers and commercialization priorities across product categories, technologies, and end-user settings

A product-type lens reveals distinct imperatives for consumables, instruments, and software & services. Consumables, including reagents and test kits, emphasize lot-to-lot consistency, shelf-life stability, and supply-chain continuity; instruments, spanning analyzers and readers, prioritize robustness, uptime, and ease of maintenance; while data management software and support services require secure interoperability, analytics capability, and scalable service contracts. Technology segmentation across clinical chemistry, hematology, immunoassay, and molecular diagnostics highlights divergent validation pathways and user expectations, with molecular approaches commanding particular attention for pathogen detection and high-sensitivity assays.

When examining test types such as cardiac markers, coagulation, glucose monitoring, infectious diseases, and pregnancy & fertility panels, commercialization strategies must align with clinical pathways and reimbursement realities to support clinician adoption. End-user segmentation emphasizes that ambulatory care centers and clinics prioritize rapid turnaround and portability, diagnostic laboratories focus on throughput and centralization, home care settings demand simplicity and remote data integration, and hospitals require integration into complex IT ecosystems. Application-focused strategies for cardiac care, coagulation testing, diabetes management, infectious disease diagnostics, oncology, and pregnancy testing must balance analytical rigor with user-centric design. Finally, distribution channel choices-direct sales, distributors, e-commerce platforms, and online retail-shape pricing, warranty models, and post-sale support, making channel strategy a core determinant of market reach and customer satisfaction

Regional dynamics and practical considerations for deploying point of care solutions across diverse healthcare systems and market environments

The Americas exhibit a heterogeneous mix of centralized laboratory networks and expanding point of care deployment in outpatient and home settings, which creates opportunities for technologies that integrate with electronic health records and enable remote monitoring. Across Europe, Middle East & Africa, differences in reimbursement structures and infrastructure maturity drive variable adoption curves; in some markets rapid diagnostics are being adopted as part of national screening and public health initiatives, whereas others emphasize centralized laboratory consolidation. In Asia-Pacific, growth is supported by investments in decentralized care pathways, rising chronic disease management programs, and a competitive manufacturing base that accelerates product localization.

Across all regions, regulatory alignment, reimbursement clarity, and supply chain resilience remain critical determinants of successful commercialization. Localized training and support models, tailored pricing strategies, and partnerships with clinical networks facilitate adoption. Moreover, interoperability with regional health information exchanges and telemedicine platforms enhances the clinical value proposition. Ultimately, companies that marry global best practices with local execution capabilities will unlock meaningful adoption across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Competitive landscape insights focusing on product portfolios, service propositions, and partnership models that shape market positioning

Leading companies in the point of care and rapid diagnostics space are differentiating through integrated solutions that pair modular analyzers with consumable ecosystems and cloud-enabled data platforms. Product portfolios that combine reliable reagents and adaptable test kits with instruments engineered for uptime create compelling value for diagnostic laboratories and hospital systems. Equally, organizations that invest in data management software and comprehensive support services reduce adoption friction by ensuring connectivity, compliance, and lifecycle serviceability.

Partnership models are shifting toward co-development agreements with clinical institutions and technology providers to accelerate validation and to generate real-world evidence. Distribution strategies that blend direct sales with distributor partnerships and digital channels are enabling broader market reach while preserving local service capabilities. Competitive advantage increasingly depends on the ability to demonstrate outcomes, to reduce total cost of ownership, and to provide integrated post-sale support. Companies that align product development with clinician workflows and that leverage partnerships to deliver end-to-end solutions will maintain stronger positioning in a market where performance, service excellence, and interoperability determine buyer preference

Practical and prioritized recommendations for industry leaders to accelerate adoption, protect margins, and future-proof their operations

Manufacturers should prioritize modular instrument architectures that allow for component substitution and simplify servicing, thereby reducing the operational impact of supply chain disruptions. In parallel, investing in data management software that supports interoperability and remote diagnostics will enhance clinician trust and enable service-based revenue models. From a commercial perspective, aligning pricing and reimbursement strategies with clinical outcomes and total cost of care will facilitate adoption in both hospital networks and ambulatory channels.

Operationally, companies must strengthen multi-sourcing strategies, consider regional manufacturing partnerships to mitigate tariff exposure, and implement agile inventory management practices. Strategic collaborations with clinical sites for early validation and real-world evidence generation will accelerate payer engagement and clinician uptake. Finally, forging flexible distribution approaches that combine direct sales, careful distributor selection, and digital commerce will expand reach while preserving post-sale service standards. Taken together, these actions will help leaders maximize impact, sustain margins, and remain nimble in an environment characterized by rapid technological change and evolving care delivery models

Rigorous research methodology and data synthesis approach used to produce reproducible insights and validate conclusions

The research process integrated qualitative and quantitative evidence streams to create a robust understanding of market dynamics. Primary inputs included structured interviews with clinical decision-makers, procurement leaders, and product managers across hospitals, diagnostic laboratories, ambulatory care centers, and home care providers. Secondary sources encompassed peer-reviewed literature, regulatory guidance, and company disclosures to triangulate technology trends, validation requirements, and commercial models.

Data synthesis applied thematic analysis to capture common adoption barriers and enablement factors, while comparative case studies highlighted successful deployment models across different regions. Throughout, methodological safeguards ensured that conclusions relied on validated expert perspectives and documented performance characteristics rather than speculative forecasts. The approach prioritized transparency in assumptions and documented limitations to allow readers to interpret findings within the appropriate operational context. This methodological rigor produces actionable insights that are reproducible and applicable to strategy formulation, product development, and commercial planning

Concluding perspectives that synthesize strategic implications and reinforce priorities for decision-makers navigating the point of care diagnostics landscape

The rapid diagnostics ecosystem is at an inflection point where technological advances intersect with shifting care delivery models and evolving policy environments. Decision-makers must prioritize integration across hardware, consumables, and software to deliver consistent clinical value while maintaining operational resilience in the face of supply chain and trade dynamics. Equally important is the alignment of commercialization strategies with end-user workflows, reimbursement realities, and regional healthcare system characteristics.

Looking ahead, success will favor organizations that combine product excellence with robust service and data strategies, that invest in regional operational flexibility, and that cultivate partnerships to accelerate validation and adoption. By concentrating on modularity, interoperability, and outcomes-driven evidence generation, stakeholders can translate diagnostic innovations into measurable improvements in patient care. In sum, the pathway to sustainable growth rests on disciplined execution that bridges technical capability with pragmatic market implementation

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of smartphone-based lateral flow assays for decentralized infectious disease screening in low-resource settings
  • 5.2. Integration of AI algorithms in point-of-care blood analyzers for rapid cardiovascular risk assessment
  • 5.3. Development of multiplexed microfluidic cartridges enabling simultaneous detection of multiple respiratory pathogens at bedside
  • 5.4. Expansion of CRISPR-based point-of-care diagnostic platforms for rapid detection of emerging viral variants
  • 5.5. Implementation of wearable biosensor patches for continuous glucose monitoring and real-time diabetic care management
  • 5.6. Rise of direct-to-consumer rapid diagnostic kits facilitated by digital health apps and home testing services
  • 5.7. Adoption of blockchain technology for secure data sharing in decentralized point-of-care diagnostic networks
  • 5.8. Emergence of paper-based biosensing strips for cost-effective point-of-care detection of heavy metal contaminants in water samples
  • 5.9. Collaboration between diagnostic manufacturers and pharmaceutical companies for companion rapid tests in personalized oncology care

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Point of Care & Rapid Diagnostics Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Reagents
    • 8.1.2. Test Kits
  • 8.2. Instruments
    • 8.2.1. Analyzers
    • 8.2.2. Readers
  • 8.3. Software & Services
    • 8.3.1. Data Management Software
    • 8.3.2. Support Services

9. Point of Care & Rapid Diagnostics Market, by Technology

  • 9.1. Clinical Chemistry
  • 9.2. Hematology
  • 9.3. Immunoassay
  • 9.4. Molecular Diagnostics

10. Point of Care & Rapid Diagnostics Market, by Test Type

  • 10.1. Cardiac Markers
  • 10.2. Coagulation
  • 10.3. Glucose Monitoring
  • 10.4. Infectious Diseases
  • 10.5. Pregnancy & Fertility

11. Point of Care & Rapid Diagnostics Market, by End User

  • 11.1. Ambulatory Care Centers
  • 11.2. Clinics
  • 11.3. Diagnostic Laboratories
  • 11.4. Home Care Settings
  • 11.5. Hospitals

12. Point of Care & Rapid Diagnostics Market, by Application

  • 12.1. Cardiac Care
  • 12.2. Coagulation Testing
  • 12.3. Diabetes Management
  • 12.4. Infectious Disease Diagnostics
  • 12.5. Oncology
  • 12.6. Pregnancy Testing

13. Point of Care & Rapid Diagnostics Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. E-Commerce Platforms
  • 13.4. Online Retail

14. Point of Care & Rapid Diagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Point of Care & Rapid Diagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Point of Care & Rapid Diagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. Roche Diagnostics International AG
    • 17.3.3. Siemens Healthineers AG
    • 17.3.4. Danaher Corporation
    • 17.3.5. Thermo Fisher Scientific Inc.
    • 17.3.6. Becton, Dickinson and Company
    • 17.3.7. bioMerieux SA
    • 17.3.8. Quidel Corporation
    • 17.3.9. Ortho Clinical Diagnostics GmbH
    • 17.3.10. QIAGEN N.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. POINT OF CARE & RAPID DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. POINT OF CARE & RAPID DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. POINT OF CARE & RAPID DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY READERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUPPORT SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COAGULATION TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA POINT OF CARE & RAPID DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032